{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:08:47Z","timestamp":1787242127032,"version":"build-2736575974"},"reference-count":38,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2020]]},"DOI":"10.1620\/tjem.250.13","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T17:25:56Z","timestamp":1579541156000},"page":"13-23","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and Safety of Targeted Strategy for Treating Rheumatoid Arthritis Patients Aged 75 Years or Older"],"prefix":"10.1620","volume":"250","author":[{"given":"Ichiro","family":"Yoshii","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Musculoskeletal Medicine, Yoshii Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsumi","family":"Chijiwa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kochi Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Dohgo Onsen Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","unstructured":"Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham, C.O. 3rd, Birnbaum, N.S., Burmester, G.R., Bykerk, V.P., Cohen, M.D., Combe, B., Costenbader, K.H., Dougados, M., Emery, P., Ferraccioli, G., et al. (2010)  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.  <i>Ann. Rheum. Dis.<\/i>, 69, 1580-1588."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Andrews, J.S., Trupin, L., Yelin, E.H., Hough, C.L., Covinsky, K.E. &amp; Katz, P.P. (2017)  Frailty and reduced physical function go hand in hand in adults with rheumatoid arthritis: a US observational cohort study.  <i>Clin. Rheumatol.<\/i>, 36, 1031-1039.","DOI":"10.1007\/s10067-017-3541-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Atsumi, T., Yamamoto, K., Takeuchi, T., Yamanaka, H., Ishiguro, N., Tanaka, Y., Eguchi, K., Watanabe, A., Origasa, H., Yasuda, S., Yamanishi, Y., Kita, Y., Matsubara, T., Iwamoto, M., Shoji, T., et al. (2016)  The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.  <i>Ann. Rheum. Dis.<\/i>, 75, 75-83.","DOI":"10.1136\/annrheumdis-2015-207511"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bakker, M.F., Jacobs, J.W., Welsing, P.M., Verstappen, S.M., Tekstra, J., Ton, E., Geurts, M.A., van der Werf, J.H., van Albada-Kuipers, G.A., Jahangier-de Veen, Z.N., van der Veen, M.J., Verhoef, C.M., Lafeber, F.P. &amp; Bijlsma, J.W.; Utrecht Rheumatoid Arthritis Cohort Study Group (2012)  Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.  <i>Ann. Intern. Med.<\/i>, 156, 329-339.","DOI":"10.7326\/0003-4819-156-5-201203060-00004"},{"key":"5","unstructured":"Castleden, C.M. &amp; George, C.F. (1979)  The effect of ageing on the hepatic clearance of propranolol.  <i>Br. J. Clin. Pharmacol.<\/i>, 7, 49-54."},{"key":"6","unstructured":"Cooney, J.K., Law, R.J., Matschke, V., Lemmey, A.B., Moore, J.P., Ahmad, Y., Jones, J.G., Maddison, P. &amp; Thom, J.M. (2011)  Benefits of exercise in rheumatoid arthritis.  <i>J. Aging Res.<\/i>, 2011, 681640."},{"key":"7","unstructured":"Deal, C.L., Meenan, R.F., Goldenberg, D.L., Anderson, J.J., Sack, B., Pastan, R.S. &amp; Cohen, A.S. (1985)  The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration.  <i>Arthritis Rheum.<\/i>, 28, 987-994."},{"key":"8","doi-asserted-by":"crossref","unstructured":"Dixon, W.G., Abrahamowicz, M., Beauchamp, M.E., Ray, D.W., Bernatsky, S., Suissa, S. &amp; Sylvestre, M.P. (2012)  Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis.  <i>Ann. Rheum. Dis.<\/i>, 71, 1128-1133.","DOI":"10.1136\/annrheumdis-2011-200702"},{"key":"9","unstructured":"Hamazaki, Y. &amp; Minato, N. (2018)  T cell aging and immunosenescence.  http:\/\/leading.lifesciencedb.jp\/7-e005 [<i>Accessed<\/i>: December 25, 2018] (in Japanese)."},{"key":"10","unstructured":"Hirshberg, B., Muszkat, M., Schlesinger, O. &amp; Rubinow, A. (2000)  Safety of low dose methotrexate in elderly patients with rheumatoid arthritis.  <i>Postgrad. Med. J.<\/i>, 76, 787-789."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Innala, L., Berglin, E., Moller, B., Ljung, L., Smedby, T., Sodergren, A., Magnusson, S., Rantapaa-Dahlqvist, S. &amp; Wallberg-Jonsson, S. (2014)  Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study.  <i>Arthritis Res. Ther.<\/i>, 16, R94.","DOI":"10.1186\/ar4540"},{"key":"12","unstructured":"Kato, E., Sawada, T., Tahara, K., Hayashi, H., Tago, M., Mori, H., Nishino, J., Matsui, T. &amp; Tohma, S. (2017)  The age at onset of rheumatoid arthritis is increasing in Japan: a nationwide database study.  <i>Int. J. Rheum. Dis.<\/i>, 20, 839-845."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Kavanaugh, A.F. (1997)  Rheumatoid arthritis in the elderly: is it a different disease?  <i>Am. J. Med.<\/i>, 103, 40S-48S.","DOI":"10.1016\/S0002-9343(97)90007-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kawai, S. &amp; Yamamoto, K. (2006)  Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients.  <i>Rheumatology <\/i>(<i>Oxford<\/i>), 45, 441-444.","DOI":"10.1093\/rheumatology\/kei172"},{"key":"15","unstructured":"Kinirons, M.T. &amp; O\u2019Mahony, M.S. (2004)  Drug metabolism and ageing.  <i>Br. J. Clin. Pharmacol.<\/i>, 57, 540-544."},{"key":"16","unstructured":"Klotz, U. (2009)  Pharmacokinetics and drug metabolism in the elderly.  <i>Drug Metab. Rev.<\/i>, 41, 67-76."},{"key":"17","unstructured":"Kobak, S. &amp; Bes, C. (2018)  An autumn tale: geriatric rheumatoid arthritis.  <i>Ther. Adv. Musculoskelet. Dis.<\/i>, 10, 3-11."},{"key":"18","doi-asserted-by":"crossref","unstructured":"Koeller, M.D., Aletaha, D., Funovits, J., Pangan, A., Baker, D. &amp; Smolen, J.S. (2009)  Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients.  <i>Rheumatology <\/i>(<i>Oxford<\/i>), 48, 1575-1580.","DOI":"10.1093\/rheumatology\/kep291"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Martin, W.J., Shim, M., Paulus, H.E., Chaudhari, S., Feng, J., Elashoff, D., Hahn, T.J. &amp; Ranganath, V.K.;  RADIUS Investigators (2014)  Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.  <i>J. Clin. Rheumatol.<\/i>, 20, 301-305.","DOI":"10.1097\/RHU.0000000000000152"},{"key":"20","unstructured":"McKendry, R.J. &amp; Dale, P. (1993)  Adverse effects of low dose methotrexate therapy in rheumatoid arthritis.  <i>J. Rheumatol.<\/i>, 20, 1850-1856."},{"key":"21","doi-asserted-by":"crossref","unstructured":"Pease, C.T., Bhakta, B.B., Devlin, J. &amp; Emery, P. (1999)  Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors.  <i>Rheumatology <\/i>(<i>Oxford<\/i>), 38, 228-234.","DOI":"10.1093\/rheumatology\/38.3.228"},{"key":"22","unstructured":"Peckel, L. (2018)  Rheumatoid arthritis in the elderly: a new problem or an old one?  Rheumatology Arthritis Advisor.  https:\/\/www.rheumatologyadvisor.com\/rheumatoid-arthritis-advisor\/rheumatoid-arthritis-in-the-elderly\/article\/742115\/ [<i>Accessed<\/i>: December 25, 2018]."},{"key":"23","doi-asserted-by":"crossref","unstructured":"Rasch, E.K., Hirsch, R., Paulose-Ram, R. &amp; Hochberg, M.C. (2003)  Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification.  <i>Arthritis Rheum.<\/i>, 48, 917-926.","DOI":"10.1002\/art.10897"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Ruban, T.N., Jacob, B., Pope, J.E., Keystone, E.C., Bombardier, C. &amp; Kuriya, B. (2016)  The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative.  <i>Clin. Rheumatol.<\/i>, 35, 759-763.","DOI":"10.1007\/s10067-015-3031-x"},{"key":"25","unstructured":"Ruffing, V. &amp; Bingham, C.O. 3rd (2017)  Rheumatoid arthritis signs and symptoms. Johns Hopkins Arthritis Center.  [<i>Cited<\/i>: December 25, 2018].   https:\/\/www.hopkinsarthritis.org\/arthritis-info\/rheumatoid-arthritis\/ra-symptoms\/  [<i>Accessed<\/i>: September 10, 2019]."},{"key":"26","doi-asserted-by":"crossref","unstructured":"Sakamoto, K., Fukushima, Y., Ito, K., Matsuda, M., Nagata, S., Minato, N. &amp; Hattori, M. (2016)  Osteopontin in spontaneous germinal centers inhibits apoptotic cell engulfment and promotes anti-nuclear antibody production in lupus-prone mice.  <i>J. Immunol.<\/i>, 197, 2177-2186.","DOI":"10.4049\/jimmunol.1600987"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Schmajuk, G., Schneeweiss, S., Katz, J.N., Weinblatt, M.E., Setoguchi, S., Avorn, J., Levin, R. &amp; Solomon, D.H. (2007)  Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.  <i>Arthritis Rheum.<\/i>, 57, 928-934.","DOI":"10.1002\/art.22890"},{"key":"28","unstructured":"Schneeweiss, S., Setoguchi, S., Weinblatt, M.E., Katz, J.N., Avorn, J., Sax, P.E., Levin, R. &amp; Solomon, D.H. (2007)  Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis.  <i>Arthritis Rheum.<\/i>, 56, 1754-1764."},{"key":"29","unstructured":"Smolen, J.S., Aletaha, D., Bijlsma, J.W., Breedveld, F.C., Boumpas, D., Burmester, G., Combe, B., Cutolo, M., de Wit, M., Dougados, M., Emery, P., Gibofsky, A., Gomez-Reino, J.J., Haraoui, B., Kalden, J., et al. (2010)  Treating rheumatoid arthritis to target: recommendations of an international task force.  <i>Ann. Rheum. Dis.<\/i>, 69, 631-637."},{"key":"30","unstructured":"Smolen, J.S., Breedveld, F.C., Burmester, G.R., Bykerk, V., Dougados, M., Emery, P., Kvien, T.K., Navarro-Compan, M.V., Oliver, S., Schoels, M., Scholte-Voshaar, M., Stamm, T., Stoffer, M., Takeuchi, T., Aletaha, D., et al. (2016)  Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.  <i>Ann. Rheum. Dis.<\/i>, 75, 3-15."},{"key":"31","unstructured":"Solomon, D.H., Bitton, A., Katz, J.N., Radner, H., Brown, E.M. &amp; Fraenkel, L. (2014)  Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?  <i>Arthritis Rheumatol.<\/i>, 66, 775-782."},{"key":"32","doi-asserted-by":"crossref","unstructured":"Sugihara, T., Ishizaki, T., Hosoya, T., Iga, S., Yokoyama, W., Hirano, F., Miyasaka, N. &amp; Harigai, M. (2015)  Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE).  <i>Rheumatology <\/i>(<i>Oxford<\/i>), 54, 798-807.","DOI":"10.1093\/rheumatology\/keu395"},{"key":"33","unstructured":"Tan, T.C., Gao, X., Thong, B.Y., Leong, K.P., Lian, T.Y., Law, W.G., Kong, K.O., Howe, H.S., Chng, H.H. &amp; Koh, E.T.;  TTSH Rheumatoid Arthritis Study Group (2017)  Comparison of elderly- and young-onset rheumatoid arthritis in an Asian cohort.  <i>Int. J. Rheum. Dis.<\/i>, 20, 737-745."},{"key":"34","unstructured":"Tutuncu, Z., Reed, G., Kremer, J. &amp; Kavanaugh, A. (2006)  Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?  <i>Ann. Rheum. Dis.<\/i>, 65, 1226-1229."},{"key":"35","doi-asserted-by":"crossref","unstructured":"Villa-Blanco, J.I. &amp; Calvo-Alen, J. (2009)  Elderly onset rheumatoid arthritis: differential diagnosis and choice of first-line and subsequent therapy.  <i>Drugs Aging<\/i>, 26, 739-750.","DOI":"10.2165\/11316740-000000000-00000"},{"key":"36","unstructured":"Witt, L.J., Demchuk, C., Curran, J.J. &amp; Strek, M.E. (2016)  Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease.  <i>Pulm. Pharmacol. Ther.<\/i>, 36, 46-52."},{"key":"37","doi-asserted-by":"crossref","unstructured":"Wolfe, F., Caplan, L. &amp; Michaud, K. (2006)  Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.  <i>Arthritis Rheum.<\/i>, 54, 628-634.","DOI":"10.1002\/art.21568"},{"key":"38","unstructured":"Wynne, H. (2005)  Drug metabolism and ageing.  <i>J. Br. Menopause Soc.<\/i>, 11, 51-56."}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/250\/1\/250_13\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T22:57:44Z","timestamp":1579906664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/250\/1\/250_13\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.250.13","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}